loading
Schlusskurs vom Vortag:
$23.41
Offen:
$23.28
24-Stunden-Volumen:
76,453
Relative Volume:
0.08
Marktkapitalisierung:
$1.35B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-10.75
EPS:
-2.21
Netto-Cashflow:
$-106.82M
1W Leistung:
+10.94%
1M Leistung:
-10.89%
6M Leistung:
-44.78%
1J Leistung:
-42.65%
1-Tages-Spanne:
Value
$23.04
$23.88
1-Wochen-Bereich:
Value
$22.12
$23.90
52-Wochen-Spanne:
Value
$18.53
$51.61

Vera Therapeutics Inc Stock (VERA) Company Profile

Name
Firmenname
Vera Therapeutics Inc
Name
Telefon
650-770-0077
Name
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Name
Mitarbeiter
112
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-08
Name
Neueste SEC-Einreichungen
Name
VERA's Discussions on Twitter

Vergleichen Sie VERA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VERA
Vera Therapeutics Inc
23.70 1.35B 0 -107.85M -106.82M -2.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.57 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
565.08 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
628.63 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.89 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
248.36 24.70B 3.81B -644.79M -669.77M -6.24

Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-04 Eingeleitet Wolfe Research Outperform
2025-01-28 Eingeleitet Goldman Buy
2024-11-21 Eingeleitet Wells Fargo Overweight
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-01-25 Eingeleitet Oppenheimer Outperform
2024-01-08 Eingeleitet Cantor Fitzgerald Overweight
2023-12-18 Eingeleitet Raymond James Outperform
2023-11-10 Hochstufung Jefferies Hold → Buy
2023-08-16 Eingeleitet Guggenheim Buy
2023-01-04 Herabstufung Jefferies Buy → Hold
2023-01-04 Herabstufung Wedbush Outperform → Neutral
2022-07-12 Eingeleitet JP Morgan Overweight
2022-05-02 Eingeleitet H.C. Wainwright Buy
2022-04-19 Eingeleitet Wedbush Outperform
Alle ansehen

Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten

pulisher
Apr 27, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Acquired by Wells Fargo & Company MN - Defense World

Apr 27, 2025
pulisher
Apr 24, 2025

A stock that deserves closer examination: Vera Therapeutics Inc (VERA) - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Traders Purchase Large Volume of Call Options on Vera Therapeutics (NASDAQ:VERA) - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

Vera Therapeutics Inc (VERA): What Are The Positives? - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 19, 2025

When (VERA) Moves Investors should Listen - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 18, 2025

Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 18, 2025
pulisher
Apr 18, 2025

Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph

Apr 18, 2025
pulisher
Apr 17, 2025

After-Market Momentum Builds For ASP Isotopes (ASPI) Amid Secondary Listing News - Stocks Telegraph

Apr 17, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Polycythemia Vera Market to Show Remarkable Growth Trends from - openPR.com

Apr 11, 2025
pulisher
Apr 11, 2025

Polycythemia Vera Therapeutics Market Set to Witness - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Vanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 09, 2025
pulisher
Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Corebridge Financial Inc. - Defense World

Apr 06, 2025
pulisher
Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025
pulisher
Apr 05, 2025

KLP Kapitalforvaltning AS Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN - GlobeNewswire

Apr 03, 2025
pulisher
Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025
pulisher
Apr 02, 2025

Vera Therapeutics Inc [VERA] stock was sold by Fordyce Marshall at the price of US$0.3 million - knoxdaily.com

Apr 02, 2025
pulisher
Apr 01, 2025

Teacher Retirement System of Texas Acquires 3,942 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year LowWhat's Next? - MarketBeat

Mar 31, 2025
pulisher
Mar 29, 2025

69,724 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by Raymond James Financial Inc. - Defense World

Mar 29, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Vera Therapeutics validates Fair Value bearish call with 42% decline By Investing.com - Investing.com UK

Mar 26, 2025
pulisher
Mar 26, 2025

Swiss National Bank Purchases 15,700 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Relative Strength Alert For Vera Therapeutics - Nasdaq

Mar 25, 2025
pulisher
Mar 22, 2025

AlphaQuest LLC Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Bank of New York Mellon Corp Acquires 7,895 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

Arizona State Retirement System Has $532,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - The AM Reporter

Mar 15, 2025
pulisher
Mar 14, 2025

Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - simplywall.st

Mar 14, 2025
pulisher
Mar 14, 2025

Victory Capital Management Inc. Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Analysts - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Vera Therapeutics (VERA) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Growth Accelerates: 9 Strategic Hires Secure Equity Package Worth $2.3M - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MENAFN.COM

Mar 11, 2025
pulisher
Mar 08, 2025

What is HC Wainwright’s Estimate for VERA FY2025 Earnings? - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Vera Therapeutics: Does The Earlier Otsuka Launch Harm Its Prospects Much? - Seeking Alpha

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for VERA - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

JPMorgan Chase & Co. Has Lowered Expectations for Vera Therapeutics (NASDAQ:VERA) Stock Price - Defense World

Mar 06, 2025

Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Vera Therapeutics Inc-Aktie (VERA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Fordyce Marshall
PRESIDENT AND CEO
Feb 26 '25
Sale
27.65
9,075
250,882
204,665
$20.90
price up icon 1.36%
$69.80
price up icon 0.31%
$32.42
price down icon 0.60%
$24.00
price up icon 0.25%
$103.85
price down icon 0.51%
biotechnology ONC
$249.09
price down icon 0.47%
Kapitalisierung:     |  Volumen (24h):